| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/13/2011 | US20110008377 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 01/13/2011 | US20110008370 Novel use of flj25416 gene |
| 01/13/2011 | US20110008363 Erythropoietin variants |
| 01/13/2011 | US20110008357 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 01/13/2011 | US20110008354 Antibodies to apo-2 receptor polypeptides |
| 01/13/2011 | US20110008353 Identification of astrovirus va1 associated with gastroenteritis in humans |
| 01/13/2011 | US20110008351 Anticomplement polypeptides of ixodes ricinus |
| 01/13/2011 | US20110008346 Biomarkers for cardiovascular disease |
| 01/13/2011 | US20110008341 Polypeptides and methods for making the same |
| 01/13/2011 | US20110008333 Methods of inhibiting unwanted cell proliferation using hedgehog antagonists |
| 01/13/2011 | US20110008331 Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response |
| 01/13/2011 | US20110008330 Compositions and methods of tolerizing a primate to an antigen |
| 01/13/2011 | US20110008319 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 01/13/2011 | US20110008318 Toll-like receptor 5 ligands and methods of use |
| 01/13/2011 | US20110008313 tPA MUTANT IN THE TREATMENT OF ACUTE BRAIN INJURY AND NEURODEGENERATIVE DISORDERS |
| 01/13/2011 | US20110008295 Simian adenoviruses sadv-36, -42.1, -42.2, and -44 and uses thereof |
| 01/13/2011 | US20110008292 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
| 01/13/2011 | US20110008289 Hyperglycosylated polypeptide variants and methods of use |
| 01/13/2011 | US20110008283 Interferon fusion proteins |
| 01/13/2011 | US20110008280 Methods for treating viral infection using il-28 and il-29 cysteine mutants |
| 01/13/2011 | US20110008248 Peptide Antagonists of TGF-Beta Family Members and Therapeutic Uses Thereof |
| 01/13/2011 | DE202010009512U1 Collagenpulver Collagen powder |
| 01/13/2011 | DE102009032179A1 Verfahren zur Reinigung von Interferon beta A process for purifying interferon beta |
| 01/13/2011 | CA2805403A1 Bioengineered silk protein-based nucleic acid delivery systems |
| 01/13/2011 | CA2804602A1 Codon-optimized factor viii variants and synthetic liver-specific promoter |
| 01/13/2011 | CA2767612A1 Variants of plasminogen and plasmin |
| 01/13/2011 | CA2767536A1 Conserved escherichia coli immunogens |
| 01/13/2011 | CA2767519A1 Method for increasing the resistance of a plant or a part thereof to a pathogen, method for screening the resistance of a plant or part thereof to a pathogen, and use thereof |
| 01/13/2011 | CA2767503A1 Long-acting coagulation factors and methods of producing same |
| 01/13/2011 | CA2767468A1 Rock2 and rock3, two new gain-of-function variants of the cytokinin receptors ahk2 and ahk3 |
| 01/13/2011 | CA2767438A1 Method for providing fertile plants via induction of bbm during transformation |
| 01/13/2011 | CA2767251A1 Insulin preparations containing methionine |
| 01/13/2011 | CA2766856A1 Detection and visualization of the cell cycle in living cells |
| 01/13/2011 | CA2766123A1 Modified ips cells having a mutant form of human immunodeficiency virus (hiv) cellular entry gene |
| 01/13/2011 | CA2765686A1 Plants having modulated carbon partitioning and a method for making the same |
| 01/13/2011 | CA2765504A1 A method for inducing extended self-renewal of functionally differentiated somatic cells |
| 01/12/2011 | EP2273266A1 Parasporin-1 receptor and use thereof |
| 01/12/2011 | EP2272970A1 High viscosity xanthan polymer preparations |
| 01/12/2011 | EP2272966A2 Sugar and lipid metabolism regulators in plants IV |
| 01/12/2011 | EP2272962A2 Polynucleotides and polypeptides in plants |
| 01/12/2011 | EP2272961A1 Process for producing recombinant albumin with reduced mannosylation |
| 01/12/2011 | EP2272960A1 Human protein NELL2 gene |
| 01/12/2011 | EP2272959A1 BMP-11 compositions |
| 01/12/2011 | EP2272957A2 Bitter taste receptors |
| 01/12/2011 | EP2272955A1 Tdp-43-storing cell model |
| 01/12/2011 | EP2272953A1 Corynebacterium glutamicum gene encoding phosphoenolpyruvate-protein phosphotransferase |
| 01/12/2011 | EP2272949A2 Infectious bursal disease virus antigenic isolates and vaccines |
| 01/12/2011 | EP2272875A1 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof |
| 01/12/2011 | EP2272867A1 Protein monomer, protein polymer obtained from said monomer, and device that contains them |
| 01/12/2011 | EP2272866A2 Therapeutically active alpha-MSH analogues |
| 01/12/2011 | EP2272865A2 Method of producing hydroxyalkyl starch derivatives |
| 01/12/2011 | EP2272864A2 Binding agents which inhibit myostatin |
| 01/12/2011 | EP2272863A1 Poa p 5-derivatives with reduced allergenicity and T-cell reactivity |
| 01/12/2011 | EP2272862A1 Rock2 and rock3, two new gain-of-function variants of the cytokinin receptors AHK2 and AHK3 |
| 01/12/2011 | EP2272861A1 Polyepitope carrier protein |
| 01/12/2011 | EP2272860A1 Multivalent epitope in complex with a detection marker for the early serodiagnosis of infections |
| 01/12/2011 | EP2272859A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 01/12/2011 | EP2272857A1 Modulation of glucagon receptor expression |
| 01/12/2011 | EP2272534A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 01/12/2011 | EP2272533A1 Soluble FcyR fusion proteins and methods of use thereof |
| 01/12/2011 | EP2272525A2 Adjuvant viral particle |
| 01/12/2011 | EP2272524A2 Y2 selective receptor agonists for therapeutic interventions |
| 01/12/2011 | EP2272501A1 Polymorphs of sodium 4-((4-chloro-2-hydroxybenzoyl) amino) butanoate |
| 01/12/2011 | EP2272321A2 Hypersensitive response induced resistance in plants by seed treatment |
| 01/12/2011 | EP2271765A1 Use of rhizopus amylases in granular starch hydrolysis |
| 01/12/2011 | EP2271667A2 I coral-derived collagen and methods of farming same |
| 01/12/2011 | EP2271666A1 Nrps-pks gene cluster and its manipulation and utility |
| 01/12/2011 | EP2271665A1 Highly bridged peptides from actinomadura namibiensis |
| 01/12/2011 | EP2271664A1 Novel sequences of brachyspira, immunogenic composition, methods for preparation and use thereof |
| 01/12/2011 | EP2271663A1 Novel avian astrovirus |
| 01/12/2011 | EP2271369A1 Novel therapeutical tools and methods for treating blindness |
| 01/12/2011 | EP2271356A1 Novel antimicrobial peptides |
| 01/12/2011 | EP2271355A2 Use of prokaryotic tir-domain containing proteins as therapeutic and diagnostic agents |
| 01/12/2011 | EP2087361B1 Method for evaluating obesity controller |
| 01/12/2011 | EP1814904B1 Antibiotic drosocin derivatives |
| 01/12/2011 | EP1704167B1 A method to make a peptide-carrier conjugate with a high immunogenicity |
| 01/12/2011 | EP1660524B1 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases |
| 01/12/2011 | EP1644034B1 Composition for enhancing an immune response comprising packaged virus-like particles |
| 01/12/2011 | EP1548107B1 Chromoprotein and fluoroproteins |
| 01/12/2011 | EP1537136B1 Promoters for regulation of gene expression in plant roots |
| 01/12/2011 | EP1521834B1 Use of a gene for increasing the oil content in plants |
| 01/12/2011 | EP1472347B1 Improved protein expression in bacillus subtilis |
| 01/12/2011 | EP1465927B1 Bag3 antibodies to be used in research, diagnostics and therapy for cell death-involving diseases |
| 01/12/2011 | EP1453858B1 Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines |
| 01/12/2011 | EP1412375B1 Alteration of oil traits in plants |
| 01/12/2011 | EP1392825B1 Phosphotriesterase from agrobacterium radiobacter p230 |
| 01/12/2011 | EP1362113B1 Constitutive promoter from arabidopsis |
| 01/12/2011 | EP1302541B1 Method for recognizing bacterial DNA |
| 01/12/2011 | EP1272206B1 A chicken II GnRH analog for use in reducing tumor cell growth |
| 01/12/2011 | EP1109831B1 Cyctotoxic peptides modified by bulky or lipophilic moieties |
| 01/12/2011 | EP1105479B1 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 01/12/2011 | EP1003782B1 Ligand for herpes simplex virus entry mediator and methods of use |
| 01/12/2011 | EP0821736B1 Bacteriocins |
| 01/12/2011 | CN1982336B Human pancreas glucagon sample peptide-1-derivative, its production and use |
| 01/12/2011 | CN1943781B Orally administered peptides to ameliorate atherosclerosis |
| 01/12/2011 | CN1865283B Solid phase polypeptide synthesis preparation method for salcatonin |
| 01/12/2011 | CN1816566B VEGF traps and therapeutic uses thereof |
| 01/12/2011 | CN1688605B Novel immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes |
| 01/12/2011 | CN1675245B Monoclonal antibody hPAM4 |
| 01/12/2011 | CN101946001A Polypeptide-nucleic acid conjugates and uses thereof |